SS Innovations International (NASDAQ:SSII) Reaches New 52-Week Low - Here's What Happened

Key Points

• SS Innovations International hit a new 52-week low of $2.65 during Monday trading, with the stock remaining well below its 50-day and 200-day moving averages.
• Analyst sentiment remains negative: Weiss Ratings maintained a “sell” rating, while Wall Street Zen upgraded the stock to “hold.” MarketBeat reports a consensus “Sell” rating and a $7.00 price target.
• The company reported a quarterly loss of $0.01 per share on $13.94 million in revenue, alongside negative net margin and return on equity. CEO Srivastava Sudhir also sold 33,333 shares for approximately $100,000.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report) hit a new 52-week low during mid-day trading on Monday. The company traded as low as $2.65 and last traded at $2.6970, with a volume of 7929 shares changing hands. The stock had previously closed at $2.67.

Analysts Set New Price Targets

A number of research analysts have issued reports on SSII shares. Weiss Ratings reissued a "sell (e+)" rating on shares of SS Innovations International in a research note on Friday, July 17th. Wall Street Zen raised shares of SS Innovations International from a "sell" rating to a "hold" rating in a research note on Sunday, June 28th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of "Sell" and a consensus target price of $7.00.

SS Innovations International Stock Up 0.9%

The firm has a fifty day moving average of $3.46 and a 200-day moving average of $3.87. The firm has a market cap of $540.02 million, a P/E ratio of -44.92 and a beta of -1.79.

SS Innovations International (NASDAQ:SSII - Get Free Report) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.01) earnings per share for the quarter. SS Innovations International had a negative return on equity of 26.77% and a negative net margin of 23.73%.The company had revenue of $13.94 million for the quarter.

Insider Activity at SS Innovations International

In other news, CEO Srivastava Sudhir sold 33,333 shares of the business's stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $3.00, for a total transaction of $99,999.00. Following the transaction, the chief executive officer directly owned 108,520,928 shares in the company, valued at $325,562,784. The trade was a 0.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Hedge Funds Weigh In On SS Innovations International

A number of institutional investors have recently bought and sold shares of SSII. Eversept Partners LP increased its holdings in shares of SS Innovations International by 46.2% during the 1st quarter. Eversept Partners LP now owns 110,157 shares of the company's stock worth $551,000 after acquiring an additional 34,799 shares during the last quarter. Inspire Investing LLC raised its position in shares of SS Innovations International by 26.4% in the first quarter. Inspire Investing LLC now owns 104,624 shares of the company's stock valued at $523,000 after buying an additional 21,851 shares in the last quarter. Finally, IFC & Insurance Marketing Inc. grew its holdings in shares of SS Innovations International by 47.7% during the 1st quarter. IFC & Insurance Marketing Inc. now owns 16,730 shares of the company's stock worth $84,000 after purchasing an additional 5,400 shares in the last quarter.

About SS Innovations International

SS Innovations International Inc is a medical technology company focused on developing and commercializing robotic-assisted surgical systems. Its principal platform, the SSI MANTRA surgical robotic system, is designed to support minimally invasive procedures by providing surgeons with enhanced visualization, precision and instrument control.

The company also develops related surgical instruments, accessories and technologies intended for use across a range of specialties. Its products are aimed at hospitals and surgical teams seeking robotic assistance for procedures while supporting operating-room efficiency and improved patient care.

SS Innovations was founded by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.